Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Genomic Health, Inc.    GHDX   US37244C1018

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
27.85(c) 27.08(c) 27.01(c) 27.11(c) 27.24(c) Last
191 269 163 005 259 377 297 064 243 498 Volume
+2.24% -2.76% -0.26% +0.37% +0.48% Change
More quotes
Financials ($)
Sales 2015 293 M
EBIT 2015 -28,1 M
Net income 2015 -23,8 M
Finance 2015 120 M
Yield 2015 -
Sales 2016 336 M
EBIT 2016 2,87 M
Net income 2016 2,10 M
Finance 2016 151 M
Yield 2016 -
PER 2015 -
PER 2016 514,93
EV / Sales 2015 2,59x
EV / Sales 2016 2,16x
Capitalization 879 M
More Financials
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
More about the company
Surperformance© ratings of Genomic Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMIC HEALTH, INC.
05/21 GENOMIC HEALTH : GHDX) is Trading Higher on Unusual Volume for May 21
05/21 GENOMIC HEALTH : Announces Favorable Draft Local Coverage Determination from Pal..
05/20 GENOMIC HEALTH : St. Gallen International Breast Cancer Guidelines for the Third..
05/20 GENOMIC HEALTH : Oncotype DX Prostate Cancer Test Improves Risk Assessment for ..
05/20 GENOMIC HEALTH : UCSF-led Study Shows Oncotype DX and MRI May Provide Independe..
05/18 GENOMIC HEALTH : Advances Liquid Biopsy Pipeline, Shows Ability to Accurately Mo..
05/15 GENOMIC HEALTH : Oncotype DX Prostate Cancer Test Improves Risk Assessment for ..
05/14 GENOMIC HEALTH : New Chemotherapy Study Findings Reported from X. Pivot and Co-A..
More news
Sector news : Biotechnology & Medical Research - NEC
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
05/21 ABBVIE : specifies breakdown of $21 billion Pharmacyclics deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/05 Genomic Health's (GHDX) CEO Kimberly Popovits on Q1 2015 Results - Earnings C..
05/05 Genomic Health misses by $0.04, misses on revenue
05/04 Notable earnings after Tuesday?s close
05/01 NEXT WEEK IN BIOTECH : Earnings Deluge - From GSK And Achillion To Intercept And..
02/12 GENOMIC HEALTH : 2014 Financial Results Predict Strong 2015


Comments 
Advertisement
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions